BioTime, CIRM Reach Agreement on Stem Cell Lines

Under the deal, BioTime will provide research-grade and GMP-grade cell lines to researchers in California.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories